Nasdaq: GH
Guardant Health insiders
The officers, directors and 10% owners of Guardant Health, Inc. who hold the most stock, valued at the live GH price.
$145.59
GH today +$450K (+0.31%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 10
- Their GH stock
- $1.26B
- Market value
- $19.70B
- Held by ranked insiders
- 6.39%
Insiders by value of GH holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | AmirAli Talasaz | Co-Chief Executive Officer | 4,139,078 | $603M | 3.06% | 421st |
| 2 | Helmy Eltoukhy | Co-Chief Executive Officer | 4,053,853 | $590M | 3.00% | 428th |
| 3 | Darya Chudova | Chief Technology Officer | 138,366 | $20.1M | 0.10% | 5166th |
| 4 | Craig Eagle | Chief Medical Officer | 72,001 | $10.5M | <0.1% | 8346th |
| 5 | Chris Freeman | Chief Commercial Officer | 69,647 | $10.1M | <0.1% | 8686th |
| 6 | Michael Brian Bell | Chief Financial Officer | 55,182 | $8.0M | <0.1% | 10349th |
| 7 | Kumud Kalia | Chief Information Officer | 42,773 | $6.2M | <0.1% | 12442nd |
| 8 | John G. Saia | Chief Legal Officer | 42,348 | $6.2M | <0.1% | 12525th |
| 9 | Vijaya Gadde | Director | 28,517 | $4.2M | <0.1% | 11248th |
| 10 | Steve Krognes | Director | 7,906 | $1.2M | <0.1% | 6089th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Guardant Health; see each profile for the filing.